Treatment failure is partly driven by immunosuppressive cells such as myeloid-derived suppressor cells (MDSCs) and regulatory T cells (Tregs) which restrain the activities of anti-tumour CD8+ T cells. This evidence concerns the gene CD8A and neoplasm.